Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 6, 2020
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
[ Thu, Aug 06th 2020
] - WOPRAI
Wed, August 5, 2020
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
[ Wed, Aug 05th 2020
] - WOPRAI
Joseph Schwartz Maintained (BMRN) at Buy with Increased Target to $140 on, Aug 5th, 2020
Joseph Schwartz of SVB Leerink, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Increased Target from $130 to $140 on, Aug 5th, 2020.
Joseph has made no other calls on BMRN in the last 4 months.
There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, all agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $125 on, Wednesday, July 8th, 2020
